Elevated MCP-1 expression has been associated with adverse pregnancy outcomes including preeclampsia [32], intrauterine growth restriction, spontaneous abortion, pregnancy loss [22] and preterm delivery [33]. This evidence concerns the gene CCL2 and fetal growth restriction.